Companies

Editas Medicine, Inc. (EDIT) SEC filings

CIK 0001650664 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)40.5 M78.1 M
Net income (USD)-220.4 M-192.5 M-116.0 M
Diluted EPS (USD/shares)-1.8-2.02

Latest filings

FiledFormDescriptionPeriod
2026-10-088-K8-K items 7.01,8.01,9.012026-10-08
2026-09-094FORM 42026-09-08
2026-09-093FORM 32026-09-08
2026-09-09S-8S-8
2026-09-08EFFECTEFFECT items ,,
2026-09-044FORM 42026-09-03
2026-09-044FORM 42026-09-03
2026-09-044FORM 42026-09-03
2026-08-31S-3S-3
2026-08-31144144
2026-08-31144144
2026-08-14SCHEDULE 13GSCHEDULE 13G
2026-08-074FORM 42026-08-06
2026-08-073FORM 32026-08-06
2026-08-054FORM 42026-08-03
2026-08-0510-Q10-Q2026-06-30
2026-08-058-K8-K items 2.02,5.02,9.012026-08-03
2026-07-294FORM 42026-07-28
2026-07-29SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-21144144
2026-06-224FORM 42026-06-17
2026-06-224FORM 42026-06-17
2026-06-224FORM 42026-06-17
2026-06-224FORM 42026-06-17
2026-06-224FORM 42026-06-17

Forms on file (last 1,000): 4 298, 8-K 131, 3 45, SC 13G/A 43, 10-Q 32, 144 23, CT ORDER 14, 424B5 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=EDIT (0.002 USD), /gw/filings/filings?ticker=EDIT&form=8-K, /gw/filings/facts?ticker=EDIT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange